Class IITerminatedD-0098-2018
Drug recall · December 6, 2017
Liothyronine Sodium Tablets recall
Why: Failed Dissolution Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
- Lots / codes
Lot: #:16F649, Exp: May 2018
- Quantity
- 11,364 bottles
- Company
- Mayne Pharma Inc, Greenville, NC
- Distribution
- Nationwide within USA
- Initiated
- November 9, 2017 · Voluntary: Firm initiated
- Classified
- November 29, 2017
- Reported
- December 6, 2017
- Ended
- May 11, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Liothyronine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.